ArticleInternational journal of clinical oncology2024

Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).

Yutaka Ogata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.